bosentan anhydrous has been researched along with Muscle Contraction in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrish, JC; Bird, E; Chen, P; Chong, S; Gu, Z; Hermsmeier, M; Humphreys, WG; Koplowitz, B; Leith, L; Liu, EC; Marino, A; Mathur, A; Moreland, S; Morrison, RA; Murugesan, N; Spergel, S; Trippodo, N; Waldron, T; Webb, ML; Young, M; Zhang, R | 1 |
| De Mey, JG; Janssen, B; Lemkens, P; Meens, MJ; Nelissen, J; Peters, SL; Schiffers, PM; Spijkers, LJ | 1 |
| Besler, C; Bigler, L; Dörries, C; Hermann, M; Lüscher, TF; Ruschitzka, F; Shaw, SG; Simic, B; Stalder, U | 1 |
| Datar, SA; Fineman, JR; Oishi, P | 1 |
| Yoshibayashi, M | 1 |
| Lüscher, TF; Tschudi, MR | 1 |
| Bakken, IJ; Edvinsson, L; Elsås, T; Sjaavaag, I; Vincent, MB; White, LR | 1 |
| Gater, PR; Renzetti, LM; Wasserman, MA | 1 |
| Lüscher, TF; Moreau, P; Takase, H | 1 |
| Dessy, C; Godfraind, T; Morel, N; Salomone, S | 1 |
| Samejima, H; Shinkai-Goromaru, M; Takayanagi, I | 1 |
| Barnes, PJ; Belvisi, MG; Kawikova, I; Takahashi, T; Warner, TD; Yacoub, MH | 1 |
| Erdem, SR; Tuncer, M; Yaşar, U | 1 |
| Bellissant, E; Durand-Castel, X; Goineau, S; Guillo, P; Pape, D | 1 |
| Berkane, N; Blandin, V; Breittmayer, JP; Ferrari, E; Frelin, C; Talbodec, A; Vigne, P | 1 |
| Lau, WA; Pennefather, JN; Salamoussa, A; Ventura, S | 1 |
2 review(s) available for bosentan anhydrous and Muscle Contraction
| Article | Year |
|---|---|
Advances in the management of pediatric pulmonary hypertension.
Topics: Animals; Antihypertensive Agents; Bosentan; Child; Citrulline; Drug Therapy, Combination; Endothelium, Vascular; Hemodynamics; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Muscle Contraction; Persistent Fetal Circulation Syndrome; Phosphodiesterase 5 Inhibitors; Piperazines; PPAR gamma; Prostaglandins; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vascular Resistance; Vasoconstriction; Ventricular Function, Right | 2011 |
[Pathophysiological significance of endothelin in pulmonary hypertension].
Topics: Biomarkers; Bosentan; Cell Division; Drug Design; Endothelin Receptor Antagonists; Endothelins; Humans; Hypertension, Pulmonary; Muscle Contraction; Muscle, Smooth, Vascular; Severity of Illness Index; Sulfonamides | 2004 |
14 other study(ies) available for bosentan anhydrous and Muscle Contraction
| Article | Year |
|---|---|
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective
Topics: Administration, Oral; Animals; Blood Pressure; Caco-2 Cells; Carotid Arteries; CHO Cells; Cricetinae; Endothelin Receptor Antagonists; Humans; In Vitro Techniques; Isoxazoles; Macaca fascicularis; Male; Muscle Contraction; Oxazoles; Rabbits; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Structure-Activity Relationship; Sulfonamides | 2003 |
Dual NEP/ECE inhibition improves endothelial function in mesenteric resistance arteries of 32-week-old SHR.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzazepines; Bosentan; Endothelin-Converting Enzymes; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; Hypertension; Losartan; Mesenteric Arteries; Muscle Contraction; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Protease Inhibitors; Rats; Rats, Inbred SHR; Sulfonamides; Vascular Resistance | 2017 |
Torcetrapib impairs endothelial function in hypertension.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Aorta; Blood Pressure; Bosentan; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Hypertension; Immunohistochemistry; Intercellular Adhesion Molecule-1; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; Quinolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Renin-Angiotensin System; Sulfonamides; Superoxides; Vascular Cell Adhesion Molecule-1 | 2012 |
Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Azepines; Benzazepines; Bosentan; Endothelin Receptor Antagonists; Endothelins; Humans; In Vitro Techniques; Indoles; Mammary Arteries; Muscle Contraction; Plasmids; Receptors, Angiotensin; Receptors, Endothelin; Sulfonamides; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents; Viper Venoms | 1994 |
Vasoactivity mediated by endothelin ETA and ETB receptors in isolated porcine ophthalmic artery.
Topics: Animals; Azepines; Bosentan; Dinoprost; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; In Vitro Techniques; Indoles; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Ophthalmic Artery; Receptors, Endothelin; Sulfonamides; Swine; Vasoconstrictor Agents; Viper Venoms | 1996 |
Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea.
Topics: Adult; Aged; Animals; Bosentan; Bronchi; Drug Interactions; Endothelin-1; Female; Guinea Pigs; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Peptides, Cyclic; Receptors, Endothelin; Sulfonamides; Trachea; Viper Venoms | 1996 |
Effect of endothelin antagonists on the responses to prostanoid endothelium-derived contracting factor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Bosentan; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Rats; Rats, Inbred WKY; Receptors, Endothelin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Vasoconstrictor Agents | 1996 |
Inhibition by bosentan, an endothelin antagonist, of the hypersensitivity to Ca2+ channel activator evoked by salt-loading in basilar artery of stroke-prone spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Basilar Artery; Bosentan; Calcium Channel Agonists; Endothelin Receptor Antagonists; Muscle Contraction; Rats; Rats, Inbred SHR; Sodium Chloride; Sulfonamides | 1996 |
The significant role of endothelin-3 in potentiating electrically stimulated contractions in the rat iris sphincter.
Topics: Animals; Bosentan; Electric Stimulation; Endothelin-1; Endothelin-3; Endothelins; Iris; Male; Muscle Contraction; Muscle, Smooth; Protein Precursors; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides; Viper Venoms | 1997 |
Contraction of human airway smooth muscle by endothelin-1 and IRL 1620: effect of bosentan.
Topics: Adolescent; Adult; Bosentan; Bronchi; Child; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Peptide Fragments; Sulfonamides | 1997 |
The possible role of endothelin(s) in cyclosporine A preparations--induced contraction of guinea pig isolated gallbladder strips.
Topics: Animals; Bosentan; Cyclosporine; Endothelins; Female; Gallbladder; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Pharmaceutical Vehicles; Sphincter of Oddi; Sulfonamides; Verapamil | 1998 |
Endothelin, but not angiotensin II, contributes to the hypoxic contractile response of large isolated pulmonary arteries in the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Bosentan; Calcium; Calcium Channel Blockers; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Extracellular Space; Glycopeptides; Hypoxia; In Vitro Techniques; Indoles; Lisinopril; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Pulmonary Artery; Rats; Rats, Wistar; Sulfonamides | 1999 |
Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.
Topics: Allosteric Regulation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Aspirin; Biological Transport; Bosentan; Calcium; Cells, Cultured; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Humans; Mammary Arteries; Muscle Contraction; Rats; Receptors, Endothelin; Sodium Salicylate; Sulfonamides | 2000 |
The contractile effects of endothelins on the smooth muscle of the rat prostate gland.
Topics: Animals; Bosentan; Dose-Response Relationship, Drug; Electric Stimulation; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-2; Endothelin-3; Endothelins; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Oligopeptides; Peptides, Cyclic; Piperidines; Prostate; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Vasoconstrictor Agents; Viper Venoms | 2000 |